Synergistic enzymatic and bioorthogonal reactions for selective prodrug activation in living systems
The side effects of cancer drugs limit their utility. Here, the authors developed a method in which an inactive (prodrug) version of the cancer drug doxorubicin enters tumour cells and then gets activated inside the cells upon a trigger facilitated by enzyme-instructed supramolecular self-assembly.
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2018
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/6e007d35dea8437d9308ae7e95626469 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|